Lidocaine intravesicular - Plethora Solutions

Drug Profile

Lidocaine intravesicular - Plethora Solutions

Alternative Names: Intravesical alkalized lidocaine (PSD597) - Plethora Solutions; PSD 597

Latest Information Update: 28 May 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Queens University
  • Developer Plethora Solutions
  • Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Interstitial cystitis; Perioperative pain

Most Recent Events

  • 24 Sep 2013 Biomarkers information updated
  • 25 Feb 2013 Discontinued - Phase-II for Interstitial cystitis in Canada (Intravesicular)
  • 25 Feb 2013 Discontinued - Phase-II for Interstitial cystitis in USA (Intravesicular)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top